Literature DB >> 23054879

Palliative care.

Michael H Levy1, Michael D Adolph, Anthony Back, Susan Block, Shirley N Codada, Shalini Dalal, Teresa L Deshields, Elisabeth Dexter, Sydney M Dy, Sara J Knight, Sumathi Misra, Christine S Ritchie, Todd M Sauer, Thomas Smith, David Spiegel, Linda Sutton, Robert M Taylor, Jennifer Temel, Jay Thomas, Roma Tickoo, Susan G Urba, Jamie H Von Roenn, Joseph L Weems, Sharon M Weinstein, Deborah A Freedman-Cass, Mary Anne Bergman.   

Abstract

These guidelines were developed and updated by an interdisciplinary group of experts based on clinical experience and available scientific evidence. The goal of these guidelines is to help patients with cancer experience the best quality of life possible throughout the illness trajectory by providing guidance for the primary oncology team for symptom screening, assessment, palliative care interventions, reassessment, and afterdeath care. Palliative care should be initiated by the primary oncology team and augmented by collaboration with an interdisciplinary team of palliative care experts.

Entities:  

Mesh:

Year:  2012        PMID: 23054879     DOI: 10.6004/jnccn.2012.0132

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  27 in total

1.  Early palliative care in cancer treatment: rationale, evidence and clinical implications.

Authors:  Lynn Howie; Jeffrey Peppercorn
Journal:  Ther Adv Med Oncol       Date:  2013-11       Impact factor: 8.168

2.  Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.

Authors:  Natalie J Miller; Shailender Bhatia; Upendra Parvathaneni; Jayasri G Iyer; Paul Nghiem
Journal:  Curr Treat Options Oncol       Date:  2013-06

3.  Integration of oncology and palliative care: a systematic review.

Authors:  David Hui; Yu Jung Kim; Ji Chan Park; Yi Zhang; Florian Strasser; Nathan Cherny; Stein Kaasa; Mellar P Davis; Eduardo Bruera
Journal:  Oncologist       Date:  2014-12-05

4.  Development of a Community-Based Palliative Care Screening Tool for Underserved Older Adults With Chronic Illnesses.

Authors:  Angela Ghesquiere; Daniel S Gardner; Caitlin McAfee; Cara Kenien; Elizabeth Capezuti; Elissa Kozlov; Jo Anne Sirey; M Carrington Reid
Journal:  Am J Hosp Palliat Care       Date:  2018-01-03       Impact factor: 2.500

5.  Do patients with advanced cancer and unmet palliative care needs have an interest in receiving palliative care services?

Authors:  Yael Schenker; Seo Young Park; Rachael Maciasz; Robert M Arnold
Journal:  J Palliat Med       Date:  2014-03-27       Impact factor: 2.947

6.  End of life care for glioblastoma patients at a large academic cancer center.

Authors:  Kamini E Kuchinad; Roy Strowd; Anne Evans; W Anthony Riley; Thomas J Smith
Journal:  J Neurooncol       Date:  2017-05-20       Impact factor: 4.130

Review 7.  Integrating palliative care into the trajectory of cancer care.

Authors:  David Hui; Eduardo Bruera
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

8.  Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; David Cella; MichaelA Zevon; Jason A LaChance; Joan L Walker; Ritu Salani; Susan C Modesitt; Robert T Morris; William H Bradley; Matthew P Boente; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2018-05-18       Impact factor: 5.482

9.  Healthcare experience among older cancer survivors: Analysis of the SEER-CAHPS dataset.

Authors:  Michael T Halpern; Matthew P Urato; Lisa M Lines; Julia B Cohen; Neeraj K Arora; Erin E Kent
Journal:  J Geriatr Oncol       Date:  2017-12-15       Impact factor: 3.599

10.  Oncologist factors that influence referrals to subspecialty palliative care clinics.

Authors:  Yael Schenker; Megan Crowley-Matoka; Daniel Dohan; Michael W Rabow; Cardinale B Smith; Douglas B White; Edward Chu; Greer A Tiver; Sara Einhorn; Robert M Arnold
Journal:  J Oncol Pract       Date:  2013-12-03       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.